Definium Therapeutics, Inc. - Common Shares — Quarterly Cash Flow (NASDAQ:DFTX)

Financials

Total assets 302.15 M275.32 M265.09 M236.92 M440.1 M401.29 M Total liabilities 60.7 M52.52 M79.69 M106.32 M107.77 M122.44 M Total equity 241.45 M222.81 M185.4 M130.6 M332.33 M278.85 M Total liabilities & shareholders' equities 302.15 M275.32 M265.09 M236.92 M440.1 M401.29 M Total debt 21.85 M22.04 M41.19 M40.38 M40.58 M40.77 M Net debt 21.85 M22.04 M-141.8 M-168.69 M-371.01 M-332.65 M

Definium Therapeutics, Inc. - Common Shares

Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.